Nuvation Bio Inc. (NUVB) income statement
NUVBNYSEPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 4/30107% above fair value
$3.78−0.12 (-3.08%)
Close on Nov 18, 2026Market cap $1.33BP/E –Yield –
Nuvation Bio Inc. income statement
Ratios
Latest available, balances at Jun 30, 2026
Profitability, TTM
- Gross margin
- –
- Operating margin
- -81.0%
- Net margin
- -88.2%
- Return on equity, FY2025
- -53.2%
Financial strength
- Current ratio
- 8.37
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- 298.1%
Valuation
- P/E ratio
- –
- Price to sales
- 7.81
- Price to book
- 5.23
- Dividend yield
- –
See a number that looks wrong?